Valuation Metrics Reflect Changing Market Perception
As of 28 July 2026, Mphasis trades at ₹2,330.85, up 1.81% from the previous close of ₹2,289.30. Despite this modest uptick, the company’s valuation grade has deteriorated, moving from very expensive to expensive. The current P/E ratio stands at 22.89, a level that, while lower than some peers, still suggests a premium relative to historical averages for the sector.
The price-to-book value (P/BV) ratio is 4.13, indicating that the stock is trading at over four times its book value. This multiple remains elevated, reflecting investor expectations of sustained earnings growth and return on equity (ROE). Mphasis’s latest ROE is a robust 17.58%, supported by a return on capital employed (ROCE) of 23.60%, underscoring operational efficiency and capital utilisation.
Peer Comparison Highlights Relative Valuation
When compared with key competitors, Mphasis’s valuation appears more moderate but still expensive. Oracle Financial Services, Persistent Systems, Infosys Edge (India), and Coforge all maintain very expensive valuations, with P/E ratios ranging from 28.28 to 54.48 and EV/EBITDA multiples between 20.2 and 64.54. L&T Technology, another sector peer, is also classified as expensive with a P/E of 27.49.
In contrast, Mphasis’s EV/EBITDA ratio of 14.27 is comparatively lower, suggesting a more reasonable enterprise value relative to earnings before interest, tax, depreciation and amortisation. However, the PEG ratio of 2.08 indicates that the stock’s price is still high relative to its earnings growth rate, which may temper enthusiasm among growth-focused investors.
Stock Performance Versus Sensex: Mixed Returns
Examining Mphasis’s stock returns relative to the Sensex reveals a mixed picture. Year-to-date, the stock has declined 16.48%, underperforming the Sensex’s 9.84% fall. Over the past year, Mphasis has dropped 11.49%, compared to the Sensex’s 5.68% decline. Longer-term returns are more favourable, with a 10-year gain of 329.81% significantly outpacing the Sensex’s 174.18% rise. However, the 3-year and 5-year returns lag the benchmark, signalling recent challenges in maintaining momentum.
Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!
- - Hidden turnaround gem
- - Solid fundamentals confirmed
- - Large Cap opportunity
Financial Strength and Dividend Yield
Mphasis maintains a dividend yield of 2.67%, which is attractive in the context of its valuation and sector peers. The company’s EV to capital employed ratio of 4.26 and EV to sales of 2.65 further illustrate a balanced capital structure and revenue generation efficiency. These metrics support the notion that while the stock is expensive, it is backed by solid fundamentals.
Market Cap and Grade Downgrade
The downgrade from Hold to Sell on 1 February 2026 reflects a reassessment of Mphasis’s valuation and growth prospects. The Mojo Score of 44.0 and Mojo Grade of Sell indicate that the stock currently lacks sufficient upside potential relative to risk. This downgrade is significant for mid-cap investors who may have previously considered Mphasis a core holding within the Computers - Software & Consulting sector.
Price Range and Volatility
Over the past 52 weeks, Mphasis’s share price has fluctuated between ₹2,033.65 and ₹3,035.15, demonstrating considerable volatility. The current price of ₹2,330.85 is closer to the lower end of this range, which may offer some valuation comfort. However, the recent price action, with a daily high of ₹2,367.20 and low of ₹2,318.40, suggests limited upward momentum in the near term.
Sector Outlook and Risk Considerations
The Computers - Software & Consulting sector remains competitive, with many companies trading at very expensive multiples due to strong demand for digital transformation services. Mphasis’s valuation, while expensive, is more moderate than some peers, but the downgrade signals caution. Investors should weigh the company’s solid return metrics against the risk of stretched valuations and potential earnings volatility.
Is Mphasis Ltd. your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Investor Takeaway
For investors considering Mphasis, the shift in valuation grade from very expensive to expensive, combined with a Sell rating, suggests a cautious stance. While the company’s fundamentals remain strong, including high ROCE and ROE, the premium valuation and recent underperformance relative to the Sensex warrant careful analysis. The stock’s PEG ratio above 2.0 indicates that earnings growth may not fully justify the current price, especially when compared to peers with lower PEG ratios but higher absolute valuations.
Long-term investors who have held Mphasis through its impressive 10-year return of 329.81% may view the current valuation adjustment as a pause rather than a reversal. However, shorter-term traders and those seeking growth at a reasonable price might find more compelling opportunities elsewhere in the sector or across market caps.
Ultimately, Mphasis’s valuation shift highlights the importance of balancing growth expectations with price discipline in a sector characterised by rapid change and intense competition.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
